Position in AMGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$202,424
+$9,966 QoQ
Shares Held
559
-4.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#2,854
of 3,139 holders
Holding Since
Sep 2020
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fortis Group Advisors, LLC holds $10,238,680 across 11 Drug Manufacturers - General names. AMGN ranks #5 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,471 | $4,163,221 | |
| 2 | NVO |
Novo Nordisk A S
|
72,916 | $3,495,593 | |
| 3 | PFE |
Pfizer Inc
|
62,653 | $1,508,683 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,715 | $605,877 | |
| 5 | AMGN |
Amgen Inc
This page
|
559 | $202,424 | |
| 6 | JNJ |
Johnson & Johnson
|
718 | $182,350 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
246 | $31,079 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
500 | $28,810 |
All Filings in AMGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $202,424 | 559 | Shares | Sole | 2026-07-24 | |
| 2025-12-31 | $192,458 | 588 | Shares | Sole | 2026-02-06 | |
| 2020-09-30 | $252,126 | 992 | Shares | Sole | 2020-11-17 | |
| No filing history on record for this holder in this stock. | ||||||